About Seahorse Bioscience
Seahorse Bioscience is a company based in Boston (United States) founded in 2000 was acquired by Agilent in September 2015.. Seahorse Bioscience has raised $34.85 million across 5 funding rounds from investors including FLIR, Agilent and Flagship Pioneering. Seahorse Bioscience operates in a competitive market with competitors including Alamar Biosciences, Glympse Bio, Harmonic Discovery, Cellarcus Biosciences and Luceome Biotechnologies, among others.
- Headquarter Boston, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Seahorse Bioscience
Seahorse Bioscience has successfully raised a total of $34.85M across 5 strategic funding rounds. The most recent funding activity was a Series E round of $11.35 million completed in March 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series E — $11.3M
-
First Round
First Round
(01 Mar 2002)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2013 | Amount | Series E - Seahorse Bioscience | Valuation |
investors |
|
| Feb, 2010 | Amount | Series D - Seahorse Bioscience | Valuation |
investors |
|
| Mar, 2009 | Amount | Series D - Seahorse Bioscience | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Seahorse Bioscience
Seahorse Bioscience has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include FLIR, Agilent and Flagship Pioneering. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech & offline focused VC firm investing in early & growth stage startups in the US
|
Founded Year | Domain | Location | |
|
Private equity investments in life sciences businesses are managed.
|
Founded Year | Domain | Location | |
|
Early stage VC firm investing in the US and Korea
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Seahorse Bioscience
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Seahorse Bioscience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Seahorse Bioscience Comparisons
Competitors of Seahorse Bioscience
Seahorse Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Alamar Biosciences, Glympse Bio, Harmonic Discovery, Cellarcus Biosciences and Luceome Biotechnologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Ultra-high sensitivity protein analysis solutions are provided across multiplex levels.
|
|
| domain | founded_year | HQ Location |
Multiple human diseases are monitored noninvasively through urine-based analysis.
|
|
| domain | founded_year | HQ Location |
Developer of kinase inhibitor drugs for oncology
|
|
| domain | founded_year | HQ Location |
Provider of extracellular vesicle analysis assay
|
|
| domain | founded_year | HQ Location |
Assay technology is developed for identifying drugs against kinases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Seahorse Bioscience
Frequently Asked Questions about Seahorse Bioscience
When was Seahorse Bioscience founded?
Seahorse Bioscience was founded in 2000 and raised its 1st funding round 2 years after it was founded.
Where is Seahorse Bioscience located?
Seahorse Bioscience is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is Seahorse Bioscience a funded company?
Seahorse Bioscience is a funded company, having raised a total of $34.85M across 5 funding rounds to date. The company's 1st funding round was a Series D of $6M, raised on Mar 01, 2002.
What does Seahorse Bioscience do?
Seahorse Bioscience has developed an instrument system, called the Seahorse XFp Analyzer to assay the metabolic status of cells by measuring the Oxygen Consumption Rate (OCR) - a measure of the cellular respiration, and extracellular acidification rate (ECAR) - a measure of the rate of glycolysis, at regular intervals (5-8 minutes) using solid state sensor probes. The OCRECAR measurements can be used as metabolic phenotypes in various cellular assays and diagnostic tests. The company has developed both the instrumentation, as well as reagents and consumables to be used for the assays on the Seahorse XFp Analyzer. The company was acquired by Agilent Technologies in September 2015, which currently manufactures and sells the instrument system.
Who are the top competitors of Seahorse Bioscience?
Seahorse Bioscience's top competitors include Alamar Biosciences, Glympse Bio and Harmonic Discovery.
Who are Seahorse Bioscience's investors?
Seahorse Bioscience has 10 investors. Key investors include FLIR, Agilent, Flagship Pioneering, Life Sciences Partners, and Commonwealth Capital Ventures.